Danisco and Direvo sign enzyme developme
๐
Article
๐
2003
๐
Elsevier Science
โ 31 KB
reported turnover of $1.497 M ($1.177 M in 3Q 2001), R&D costs of $3.489 M ($3.804 M), an operating loss of $4.176 M (operating loss of $6.288 M), a net loss of $3.896 M (net loss of $5.860 M), and a loss per share of $0.22 (loss per share $0.37). For the nine months to 30 Sep 2002 Catalytica Energy